# Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury

> **NCT06937307** · PHASE2 · RECRUITING · sponsor: **Giuseppe Cullaro, MD** · enrollment: 75 (estimated)

## Conditions studied

- Acute Kidney Injury
- Cirrhosis
- Decompensated Cirrhosis of Liver

## Interventions

- **DRUG:** Droxidopa capsules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06937307
- **Lead sponsor:** Giuseppe Cullaro, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937307, "Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06937307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*